Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-08-02 Option Award |
2021-08-03 4:34 pm |
N/A 2031-08-01 |
Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer |
67,500 | $0 | 67,500 (Direct) |
View |
2021-08-02 Option Award |
2021-08-03 4:33 pm |
N/A 2031-08-01 |
Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks |
112,500 | $0 | 112,500 (Direct) |
View |
2021-07-20 Option Award |
2021-07-22 4:36 pm |
N/A 2031-07-19 |
Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks |
50,000 | $0 | 50,000 (Direct) |
View |
2021-07-06 Option Award |
2021-07-08 4:33 pm |
N/A 2031-07-05 |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2021-07-08 4:32 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
0 | $0 | 0 (Direct) |
View |
2021-06-14 Option Award |
2021-06-15 4:33 pm |
N/A 2031-06-13 |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2021-06-15 4:29 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
0 | $0 | 0 (Direct) |
View |
2021-06-01 Option Award |
2021-06-03 6:36 pm |
N/A 2031-05-31 |
Magenta Therapeutics Inc. | MGTA | McGeorge Anne Director |
18,188 | $0 | 18,188 (Direct) |
View |
2021-06-01 Option Award |
2021-06-03 6:36 pm |
N/A 2031-05-31 |
Magenta Therapeutics Inc. | MGTA | Lawton Alison Frances Director |
18,188 | $0 | 18,188 (Direct) |
View |
2021-06-01 Option Award |
2021-06-03 6:35 pm |
N/A 2031-05-31 |
Magenta Therapeutics Inc. | MGTA | Booth Bruce Director |
18,188 | $0 | 18,188 (Direct) |
View |
2021-06-01 Option Award |
2021-06-03 6:34 pm |
N/A 2031-05-31 |
Magenta Therapeutics Inc. | MGTA | RONNEBERG AMY L Director |
18,188 | $0 | 18,188 (Direct) |
View |
2021-06-01 Option Award |
2021-06-03 6:33 pm |
N/A 2031-05-31 |
Magenta Therapeutics Inc. | MGTA | BONNEY MICHAEL W Director |
18,188 | $0 | 18,188 (Direct) |
View |
2021-06-01 Option Award |
2021-06-03 6:30 pm |
N/A 2031-05-31 |
Magenta Therapeutics Inc. | MGTA | Scadden David Director |
18,188 | $0 | 18,188 (Direct) |
View |
2021-06-01 Option Award |
2021-06-03 6:30 pm |
N/A 2031-05-31 |
Magenta Therapeutics Inc. | MGTA | Daniel Thomas O Director |
18,188 | $0 | 18,188 (Direct) |
View |
2021-06-01 Option Award |
2021-06-03 6:27 pm |
N/A 2031-05-31 |
Magenta Therapeutics Inc. | MGTA | Borisy Alexis Director |
18,188 | $0 | 18,188 (Direct) |
View |
2021-06-01 Option Award |
2021-06-03 6:27 pm |
N/A 2031-05-31 |
Magenta Therapeutics Inc. | MGTA | Albers Jeffrey W. Director |
18,188 | $0 | 18,188 (Direct) |
View |
2021-04-19 Option Award(A) |
2021-05-17 5:07 pm |
N/A 2031-04-18 |
Magenta Therapeutics Inc. | MGTA | Nichols David Wayne Chief Technical Officer |
175,000 | $0 | 175,000 (Direct) |
View |
2021-04-19 Option Award |
2021-04-20 5:04 pm |
N/A 2031-04-18 |
Magenta Therapeutics Inc. | MGTA | Nichols David Wayne Chief Technical Officer |
175,000 | $0 | 175,000 (Direct) |
View |
2021-02-11 Other |
2021-02-16 6:15 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Atlas Venture Fund X L.P. 10% Owner |
968,726 | $0 | 4,117,125 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 5:58 pm |
N/A 2031-02-10 |
Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks |
12,500 | $0 | 12,500 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 5:48 pm |
N/A 2031-02-10 |
Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR See Remarks |
72,500 | $0 | 72,500 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 5:47 pm |
N/A 2031-02-10 |
Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks |
67,700 | $0 | 67,700 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 5:46 pm |
N/A 2031-02-10 |
Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks |
112,500 | $0 | 112,500 (Direct) |
View |
2021-02-11 Option Award |
2021-02-16 5:42 pm |
N/A 2031-02-10 |
Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer |
67,500 | $0 | 67,500 (Direct) |
View |
2020-12-22 Option Award |
2020-12-23 7:13 pm |
N/A 2030-12-21 |
Magenta Therapeutics Inc. | MGTA | Lawton Alison Frances Director |
36,377 | $0 | 36,377 (Direct) |
View |
Ownership |
2020-12-23 7:09 pm |
N/A 2027-09-26 |
Magenta Therapeutics Inc. | MGTA | Lawton Alison Frances Director |
0 | $0 | 52,244 (Direct) |
View |
2020-11-02 Option Award |
2020-11-04 4:39 pm |
N/A 2030-11-01 |
Magenta Therapeutics Inc. | MGTA | Mahoney Stephen F. See Remarks |
435,000 | $0 | 435,000 (Direct) |
View |
Ownership |
2020-10-13 8:21 pm |
N/A 2027-09-26 |
Magenta Therapeutics Inc. | MGTA | Driscoll Cindy See Remarks |
0 | $0 | 195,540 (Direct) |
View |
2020-09-14 Option Award |
2020-09-16 4:37 pm |
N/A 2030-09-13 |
Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks |
120,000 | $0 | 120,000 (Direct) |
View |